Evidence map›Paper›PMID 27342578›Full record

ArticleThyroid : official journal of the American Thyroid Association2016

Papillary Thyroid Carcinoma: Association Between Germline DNA Variant Markers and Clinical Parameters.

Jaroslaw Jendrzejewski, Sandya Liyanarachchi, Rebecca Nagy, Leigha Senter, Paul E Wakely, Andrew Thomas, Fadi Nabhan, Huiling He, Wei Li, Krzysztof Sworczak and 3 more

Abstract read
In one paragraph

Article in Thyroid : official journal of the American Thyroid Association, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Genetic susceptibility to hereditary non-medullary thyroid cancer.Hereditary cancer in clinical practice · 2022
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Two distinct E3 ligases, SCFFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Jaroslaw Jendrzejewski1 Human Cancer Genetics Program, Comprehensive Cancer Center, The Ohio State University , Columbus, Ohio.
Sandya Liyanarachchi1 Human Cancer Genetics Program, Comprehensive Cancer Center, The Ohio State University , Columbus, Ohio.
Rebecca Nagy1 Human Cancer Genetics Program, Comprehensive Cancer Center, The Ohio State University , Columbus, Ohio.
Leigha Senter1 Human Cancer Genetics Program, Comprehensive Cancer Center, The Ohio State University , Columbus, Ohio.
Paul E Wakely3 Department of Pathology, The Ohio State University , Columbus, Ohio.
Andrew Thomas1 Human Cancer Genetics Program, Comprehensive Cancer Center, The Ohio State University , Columbus, Ohio.
Fadi Nabhan4 Division of Endocrinology, Diabetes and Metabolism, The Ohio State University , Columbus, Ohio.
Huiling He1 Human Cancer Genetics Program, Comprehensive Cancer Center, The Ohio State University , Columbus, Ohio.
Wei Li1 Human Cancer Genetics Program, Comprehensive Cancer Center, The Ohio State University , Columbus, Ohio.
Krzysztof Sworczak2 Department of Endocrinology and Internal Medicine, Medical University of Gdansk , Gdansk, Poland .
Matthew D Ringel4 Division of Endocrinology, Diabetes and Metabolism, The Ohio State University , Columbus, Ohio.
Lawrence S Kirschner4 Division of Endocrinology, Diabetes and Metabolism, The Ohio State University , Columbus, Ohio.
Albert de la Chapelle1 Human Cancer Genetics Program, Comprehensive Cancer Center, The Ohio State University , Columbus, Ohio.
Cancer Genetics (United States) · USThe Ohio State University · USGdańsk Medical University · PL

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Selective Modulation of Thyroidal RadioiodineP01CA124570 · NCI · OHIO STATE UNIVERSITY · PI RINGEL, MATTHEW D · 2008 to 2017
$23.4M
NCI NIH HHS P01 CA124570NCI NIH HHS P30 CA016058
6 · The paper itself

Abstract

backgroundPapillary thyroid cancer (PTC) is reported to be highly heritable in epidemiological studies. Genome-wide association studies (GWAS) have uncovered several variants associated with PTC predisposition. It remains unknown whether these variants might contribute to better clinical stratification of PTC patients.

methodsIn order to assess the usefulness of germline genetic analyses in the management of PTC patients, the genotypes of five variants (rs965513, rs944289, rs116909374, rs2439302, and rs966423) were determined in 1216 PTC patients and 1416 controls. Additionally, the expression of seven genes located close to GWAS variants (PTCSC3, MBIP, NKX2-1, FOXE1, DIRC3, PTCSC2, and NRG1) were measured in 73 PTC paired tumor/normal tissues, respectively. Next, the association was analyzed between the genotypes of the germline variants and the levels of gene expression with clinical/pathological features such as age, sex, TNM staging, multifocality status, extrathyroidal expansion, and MACIS score.

resultsThe risk allele of rs965513 was associated with larger tumor size (p = 0.025) and extrathyroidal expansion (odd ratio [OR] = 1.29, p = 0.045). The variant rs2439302 showed association with lymph node metastasis (OR = 1.24, p = 0.016), and multifocality status of the tumor (OR = 1.24, p = 0.012). The expression of MBIP was associated with T stage (p = 0.010). MBIP and PTCSC3 displayed lower expression in PTC tissue in males than in females (p = 0.025 and p = 0.036, respectively). NKX2-1 displayed lower expression in patients with N1 stage (p = 0.040).

conclusionsThe studied germline risk alleles predisposing to PTC were associated with a more aggressive course of the disease reflected by larger tumor diameter, higher multifocality rate, and more advanced N stage at the time of diagnosis. These results show that germline variants not only predispose to PTC but also might impact its clinical course. However, these associations were only moderate, and further large multi-ethnic studies are required to evaluate the usefulness of these germline variants in the clinical stratification of PTC patients.

Indexed as

Genetic MarkersPolymorphism, Single NucleotideAdultAllelesCarcinoma, PapillaryFemaleForkhead Transcription FactorsGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHumansIntracellular Signaling Peptides and ProteinsLymphatic MetastasisMaleMiddle AgedNeuregulin-1Forkhead Transcription FactorsFOXE1 protein, humanGenetic MarkersIntracellular Signaling Peptides and ProteinsMBIP protein, humanNeuregulin-1NKX2-1 protein, humanPtcsc3 untranslated RNA, humanRNA, UntranslatedThyroid Nuclear Factor 1

Identifiers

PMID27342578
PMCPMC5036310
OpenAlexW2466511224

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.